• State of Digital Clinical Trials Podcast

  • By: Richard Young
  • Podcast
State of Digital Clinical Trials Podcast cover art

State of Digital Clinical Trials Podcast

By: Richard Young
  • Summary

  • State of Digital Clinical Trials is a Veeva podcast hosted by Richard Young, Vice President of Strategy for Vault Clinical Data Management Suite at Veeva. Over the next few months, Richard will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
    Richard Young
    Show More Show Less
Episodes
  • Does Patient Choice Equal Site Headaches?
    Feb 7 2024

    The first episode of Season 2 is now out! This week, Richard Young speaks to Helen Shaw, co-founder and director of clinical operations at VCTC (a virtual site) and Marie-Claire Flavin, who joined Veeva after many years conducting clinical research for the NHS. Digital trials sometimes have a seesaw effect on different users: more flexibility for patients can mean a heavier admin burden for sites. But it doesn’t have to be this way. This episode covers novel ways that sites are using technology to expand patient choice in clinical research without compromising operational efficiency.

    Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com

    Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

    Spotify: https://lnkd.in/e5pJ7saP

    Youtube: https://bit.ly/3quY9FY

    Apple Podcasts: https://lnkd.in/efMTxybk


    Host:

    Richard Young, VP, Strategy, Veeva Vault CDMS

    Guests:

    Helen Shaw, Co-Founder and Managing Director, VCTC

    Marie-Claire Flavin, Director, Customer Success, Veeva Site Solutions (EMEA)

    Show More Show Less
    36 mins
  • Sites Are Voicing Their Concerns, But Are We Listening?
    Jan 31 2024

    In this week’s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&R (an independent research site in the Netherlands), and Bree Burks, who joined @Veeva from a clinical research background where she supported nearly 1,000 trials across different roles. Sites have been voicing their concerns for years about how the industry runs clinical studies.

    In this episode, Vivienne and Bree explain the tangible ways that sites (and patients) are hurt by inconsistent technology and the steps to make it better.

    Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com

    Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.


    Show More Show Less
    37 mins
  • Transforming Clinical Operations: What Comes Next?
    Jan 16 2024

    In this episode, Richard Young speaks with Bayer’s Head of Clinical Trial Management Services and Solutions, Emma Earl. With over 20 years of experience, Emma is perfectly positioned to comment on the rapid transformation in clinical operations and what changes are coming up on the horizon. Together they outline the major opportunities and the missing ingredients for delivering efficient and patient-centric clinical trials.

    Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com

    Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

    Show More Show Less
    32 mins

What listeners say about State of Digital Clinical Trials Podcast

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.